Bodily manifestations in the psychoanalytic process.

Psychoanal Q

Hellenic Psychoanalytical Association.

Published: July 2012

The broadening scope of psychoanalysis has brought to the fore patients whose unconscious conflicts tend to be literally played out on the stage of the body. In these cases, the body seems to be predominantly used in a concrete, not symbolic, way in order to express underlying conflicts. In a similar vein, transference and countertransference can be manifested via the body. The authors briefly discuss some of the literature on body-mind issues, and then present an extended case report to illustrate bodily manifestations in the psychoanalytic process.

Download full-text PDF

Source
http://dx.doi.org/10.1002/j.2167-4086.2012.tb00513.xDOI Listing

Publication Analysis

Top Keywords

bodily manifestations
8
manifestations psychoanalytic
8
psychoanalytic process
8
process broadening
4
broadening scope
4
scope psychoanalysis
4
psychoanalysis brought
4
brought fore
4
fore patients
4
patients unconscious
4

Similar Publications

Dissociative psychosis or dissociative schizophrenia? Comparison of two phenomena.

BMC Psychiatry

January 2025

Department of Psychiatry, University of Health Sciences, Erzurum City Hospital, Erzurum, 25100, Turkey.

Background: In recent years, researchers have reported crucial advances in the understanding of "Dissociative psychosis" and "Dissociative schizophrenia". While clinical studies in this area have been sustained for well, it remains to be established for some aspects that a clear and valid relationship exists between dissociation, childhood traumatic experiences, and schizophrenia or psychotic spectrum disorders.

Methods: To test such hypotheses, we divided the patients into two groups; the first group consisted of patients with psychotic disorders not otherwise specified (PNOS), and the second group consisted of schizophrenic patients.

View Article and Find Full Text PDF

The most common form of congenital adrenal hyperplasia (CAH) is secondary to 21-hydroxylase deficiency (21OHD). This review will summarize the clinical manifestations, recommended treatments, monitoring, clinical challenges and management strategy, and treatment challenges in special situations for infants and children with classic CAH due to 21OHD. Specifically, we review newborn screening and the initial diagnosis, glucocorticoid and mineralocorticoid treatment, and recommended monitoring, including anthropometric and laboratory measures.

View Article and Find Full Text PDF

Background/objective: : Patients with somatic symptoms are considered to have a deficiency in body-oriented mentalization; that is, the ability to perceive and interpret bodily sensations in relation to psychological states. We introduce the novel concept of psychosomatic congruence-the alignment of physical sensations with cognition and emotional states, which leads to behaviors that synchronize physical manifestations with emotional experiences and internal reflections. Despite its clinical relevance, this concept has not been empirically examined.

View Article and Find Full Text PDF

Background: Neurofibromatosis type 1 (NF1) is a rare genetic disorder affecting multiple bodily systems that predisposes to the development of tumors. It affects approximately 1 in 3000 newborns in Germany. Its clinical manifestations are diverse and complex, and its diagnostic and therapeutic management call for specialized knowledge and experience.

View Article and Find Full Text PDF

Hepatic artery pseudoaneurysm-the Mayo Clinic experience and literature review.

Front Med (Lausanne)

December 2024

Department of Hospital Internal Medicine, Mayo Clinic, Jacksonville, FL, United States.

Introduction: Hepatic artery pseudoaneurysm (HAP) is a rare and potentially life-threatening condition associated with high mortality. This study aims to review the etiology, clinical manifestations, management, and outcomes of patients diagnosed and treated for HAP at the Mayo Clinic.

Methodology: This study was a retrospective chart review of medical records for patients diagnosed and treated for hepatic artery pseudoaneurysm (HAP) at the Mayo Clinic (Florida, Minnesota, and Arizona) between September 1, 1998, and June 30, 2022.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!